We are a pure play CDMO, specialized in development and manufacturing of viral vectors.
From development to market, we provide GMP viral vectors, contributing to the success of our clients’ immunotherapies and gene therapy innovations.
Our European sites are GMP certified
AREAS OF
EXPERTISE
Vaccines
Oncolytic (Virotherapies)
Other Immunotherapies
Gene therapy
We have been a pioneer in developing and producing viral vectors since 1994.
We are grounded in the Mérieux family’s legacy of biology and vaccine expertise since 1897.
As a pure CDMO player, we contribute to the success of your immunotherapy and gene therapy innovations.
OUR LATEST NEWS
Services
We support our customers’ viral vector projects
from Preclinical, Phase I, Phase II, Phase III up to Commercial
manufacturing
and controls
support